AI-generated summary
The authors studied a folic acid-targeted liposome carrying gold nanorods and doxorubicin for combined photothermal and chemotherapy of breast cancer. They report better cellular uptake than non-targeted liposomes, DOX release of 46.38% in 60 minutes at pH 5.5 after near infrared exposure, and tumor growth inhibition in breast tumor-bearing mice. The study was conducted in cells and mice, not humans.
- Who or what was studied
- Breast tumor-bearing mice and breast cancer cells in vitro
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The evidence comes from in vitro cell assays and in vivo experiments in mice, and the abstract reports no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 154 nm, 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.